Search results for "Umbilical"

showing 10 items of 331 documents

Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).

2007

Objective Femoropopliteal bypass still is the standard surgical therapy for disabling claudication and critical ischemia. When autologous vein is not suitable synthetic or biological prostheses may be considered. Second generation glutaraldehyde tanned human umbilical vein (HUV) graft was chosen for above and below knee femoropopliteal bypass when autologous vein was not available. A single center experience regarding long-term graft function, secondary reinterventions, and potential biodegeneration of the HUV is presented. Methods Between January 1994 and January 2005, 211 consecutive femoropopliteal bypass operations with HUV (65 above knee and 146 below knee) were performed in 197 patien…

Malemedicine.medical_specialtyUmbilical VeinsTime FactorsTissue FixationAnastomosisProsthesis DesignSeverity of Illness IndexBlood Vessel Prosthesis ImplantationFixativesAneurysmIschemiamedicineHumansPopliteal ArteryDerivationVeinVascular PatencyAgedRetrospective StudiesUltrasonographyAged 80 and overBioprosthesismedicine.diagnostic_testbusiness.industryGreat saphenous veinGraft Occlusion VascularThrombosisIntermittent ClaudicationMiddle Agedmedicine.diseaseLimb SalvageThrombosisSurgeryBlood Vessel ProsthesisFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremityGlutaralAngiographySurgeryFemaleRadiologymedicine.symptombusinessClaudicationCardiology and Cardiovascular MedicineFollow-Up StudiesJournal of vascular surgery
researchProduct

Design and physicochemical characterization of poly(amidoamine) nanoparticles and the toxicological evaluation in human endothelial cells: applicatio…

2013

In this study, we investigated nanoparticles formulated by self-assembly of a biodegradable poly(amidoamine) (PAA) and a fluorescently labeled peptide, in their capacity to internalize in endothelial cells and deliver the peptide, with possible applications for brain drug delivery. The nanoparticles were characterized in terms of size, surface charge, and loading efficiency, and were applied on human cerebral microvascular endothelial cells (hCMEC/D3) and human umbilical vein endothelial cells (Huvec) cells. Cell-internalization and cytotoxicity experiments showed that the PAA-based nanocomplexes were essentially nontoxic, and the peptide was successfully internalized into cells. The result…

Materials scienceAmidoamineeducationBiomedical EngineeringBiophysicsNanoparticleBioengineeringPeptideUmbilical veinBiomaterialschemistry.chemical_compoundMETIS-302365Human Umbilical Vein Endothelial CellsPolyaminesIR-90176HumansCytotoxicityCells Culturedchemistry.chemical_classificationDrug CarriersIntracellular proteinBrainEndothelial CellsPoly(amidoamine)chemistryBiochemistryDrug deliveryMicrovesselsBiophysicsNanoparticlesOligopeptidesJournal of biomaterials science : polymer edition
researchProduct

Influence of polymer content in Ca-deficient hydroxyapatite–polycaprolactone nanocomposites on the formation of microvessel-like structures

2009

Calcium phosphate (CaP) ceramics are widely used in bone tissue engineering due to their good osteoconductivity. The mechanical properties of CaP can be modified by the addition of small volume fractions of biodegradable polymers such as polycaprolactone (PCL). Nevertheless, it is also important to evaluate how the polymer content influences cell-material or cell-cell interactions because of potential consequences for bone regeneration and vascularization. In this study we assessed the general biocompatibilty of Ca-deficient hydroxyapatite (CDHA)-PCL disks containing nominally 11 and 24% polycaprolactone using human umbilical vein endothelial cells and human primary osteoblasts. Confocal mi…

Materials scienceAngiogenesisPolyestersBiomedical EngineeringNeovascularization Physiologicchemistry.chemical_elementBiocompatible Materialsmacromolecular substancesCalciumBiochemistryUmbilical veinNanocompositeslaw.inventionBiomaterialschemistry.chemical_compoundConfocal microscopylawHumansBone regenerationMolecular BiologyMicrovesselCell ProliferationOsteoblastsReverse Transcriptase Polymerase Chain Reactiontechnology industry and agricultureEndothelial CellsGeneral MedicineAlkaline Phosphataseequipment and suppliesmusculoskeletal systemBiodegradable polymerCoculture TechniquesDurapatitechemistryMicrovesselsPolycaprolactoneCalciumBiomarkersBiotechnologyBiomedical engineeringActa Biomaterialia
researchProduct

New generation super alloy candidates for medical applications: Corrosion behavior, cation release and biological evaluation

2014

Three super alloy candidates (X1 CrNiMoMnW 24-22-6-3-2 N, NiCr21 MoNbFe 8-3-5 AlTi, CoNiCr 35-20 Mo 10 BTi) for a prolonged contact with skin are evaluated in comparison with two reference austenitic stainless steels 316L and 904L. Several electrochemical parameters were measured and determined (E(oc), E(corr), i(corr), b(a), b(c), E(b), R(p), E(crev) and coulometric analysis) in order to compare the corrosion behavior. The cation release evaluation and in vitro biological characterization also were performed. In terms of corrosion, the results reveal that the 904L steels presented the best behavior followed by the super austenitic steel X1 CrNiMoMnW 24-22-6-3-2 N. For the other two super a…

Materials scienceBiocompatible MaterialsBioengineeringElectrochemistryCell LineCorrosionBiomaterialsCoulometryMiceCationsMaterials TestingAlloysElectrochemistryHuman Umbilical Vein Endothelial CellsAnimalsHumansNichromeCorrosion behaviorCell ProliferationAusteniteTumor Necrosis Factor-alphaExtraction (chemistry)MetallurgyIntercellular Adhesion Molecule-1Stainless SteelCorrosionSuperalloyMetalsMechanics of MaterialsHeLa CellsMaterials Science and Engineering: C
researchProduct

The role of metal corrosion in inflammatory processes: induction of adhesion molecules by heavy metal ions

1994

Prosthetic devices undergo corrosion processes after implantation including the release of certain amounts of metal ions into the adjacent tissues. On reaching the bloodstream, a systemic influence of those ions may be envisaged. Cell adhesion molecules (CAMs) are recognized as an essential component of the mechanisms of endothelial damage. To study the influence of selected heavy metals on human umbilical vein endothelial cells (HUVEC) EIA methods were used to evaluate cellular expression of E-selectin, ICAM-1, VCAM-1 and GMP-140 under the influence of high (cytotoxic) very low (non-cytotoxic) concentrations of Zn, Ni, Co and Cr. The de novo synthesis of CAMs was studied with the help of m…

Materials scienceCell adhesion moleculeMetal ions in aqueous solutionBiomedical EngineeringBiophysicschemistry.chemical_elementBioengineeringZincCell morphologyIn vitroUmbilical veinBiomaterialsDe novo synthesisNickelchemistryImmunologyBiophysicsJournal of Materials Science: Materials in Medicine
researchProduct

The effect of extracellular matrix proteins on the cellular response of HUVECS and HOBS after covalent immobilization onto titanium

2014

Biomimetic surface modifications are regarded as promising approach to stimulate cellular behavior at the interface of implant materials. Aim of the study was an evaluation of the cellular response of human umbilical cord cells (HUVECS) and human osteoblasts (HOBS) on titanium covalently coated with the extracellular matrix (ECM) proteins fibrinogen, collagen, laminin, and osteopontin. For the surface modification, titanium discs were first amino-functionalized by plasma polymerization of allylamine. The ECM protein conjugation was performed using the linker molecule α, ω-bis-N-hydroxysuccinimide polyethylene glycol (Di-NHS linker). For surface characterization, infrared spectroscopy and fl…

Materials sciencePlasma GasesSpectrophotometry InfraredBiomedical EngineeringAllylaminePolymerizationAllylamineBiomaterialsExtracellular matrixchemistry.chemical_compoundLamininCell AdhesionHuman Umbilical Vein Endothelial CellsHumansSurface plasmon resonanceCell adhesionFluorescein isothiocyanateTitaniumExtracellular Matrix ProteinsOsteoblastsbiologyMetals and AlloysSurface Plasmon ResonanceFibronectinsFibronectinKineticsImmobilized ProteinschemistryBiochemistryCeramics and Compositesbiology.proteinBiophysicsSurface modificationOsteopontinCollagenLamininJournal of Biomedical Materials Research Part A
researchProduct

Is it possible to predict late antepartum stillbirth by means of cerebroplacental ratio and maternal characteristics?

2019

Objective: To examine the potential value of fetal ultrasound and maternal characteristics in the prediction of antepartum stillbirth after 32 weeks’ gestation. Methods: This was a retrospective multicenter study in Spain. In 29 pregnancies, umbilical artery pulsatility index (UA PI), middle cerebral artery pulsatility index (MCA PI), cerebroplacental ratio (CPR), estimated fetal weight (EFW), and maternal characteristics were recorded within 15 days prior to a stillbirth. The values of UA PI, MCA PI, and CPR were converted into multiples of the normal median (MoM) for gestational age and the EFW was expressed as percentile according to a Spanish reference range for gestational age. Data fr…

Middle Cerebral Arterymedicine.medical_specialtyFetal middle cerebral artery DopplerCerebroplacental ratioGestational AgeUmbilical artery dopplerUltrasonography PrenatalUmbilical Arteries03 medical and health sciencesFetal hemodynamics0302 clinical medicinePregnancyUmbilical artery DopplermedicineHumans030212 general & internal medicinereproductive and urinary physiologyRetrospective StudiesFetus030219 obstetrics & reproductive medicineObstetricsbusiness.industryFetal growth restrictionUltrasoundObstetrics and GynecologyStillbirthfemale genital diseases and pregnancy complicationsbody regionsSpainPulsatile FlowAntepartum stillbirthembryonic structuresPediatrics Perinatology and Child Healthpopulation characteristicsFemalebusinessValue (mathematics)The Journal of Maternal-Fetal & Neonatal Medicine
researchProduct

Evidence for a relationship between mitochondrial Complex I activity and mitochondrial aldehyde dehydrogenase during nitroglycerin tolerance: effects…

2012

The medical use of nitroglycerin (GTN) is limited by patient tolerance. The present study evaluated the role of mitochondrial Complex I in GIN biotransformation and the therapeutic effect of mitochondrial antioxidants. The development of GIN tolerance (in rat and human vessels) produced a decrease in mitochondrial 02 consumption. Co-incubation with the mitochondria-targeted antioxidant mitoquinone (MQ 10(-6) mol/L) or with glutathione ester (GEE, 10(-4) mol/L) blocked GTN tolerance and the effects of GTN on mitochondrial respiration and aldehyde dehydrogenase 2 (ALDH-2) activity. Biotransformation of GTN depended on the mitochondria being functionally active, particularly mitochondrial Comp…

Mitochondrial ROSMaleAntioxidantmedicine.medical_treatmentAldehyde dehydrogenaseMitochondrionmedicine.disease_causeBiochemistryAntioxidantsRats Sprague-Dawleychemistry.chemical_compoundMiceNitroglycerinCyclic GMPAortaBiotransformationbiologyDrug ToleranceGlutathioneMitochondriaVasodilationBiochemistrycardiovascular systemAntioxidantcirculatory and respiratory physiologyBiophysicsIn Vitro TechniquesALDH-2Nitric oxideCell LineOxygen ConsumptionRotenoneRespirationmedicineHuman Umbilical Vein Endothelial CellsAnimalsHumansElectron Transport Complex IDose-Response Relationship DrugNitric oxideGlutathioneCell BiologyAldehyde DehydrogenaseRatschemistryOxidative stressMutationbiology.proteinReactive Oxygen SpeciesOxidative stressBiochimica et biophysica acta
researchProduct

The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations

2020

Graphical abstract The inorganic physiological polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations. This discovery proposes polyphosphate as a new member of the host's antiviral innate immune defense.

Models Molecular0301 basic medicineAntiviral AgentsBiochemistryArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePolyphosphatesPolyphosphateHuman Umbilical Vein Endothelial Cellsotorhinolaryngologic diseasesHumansPlateletReceptorneoplasmsPharmacologychemistry.chemical_classificationBinding assayInnate immune systemSARS-CoV-2 spike S-proteinLigand binding assayPolyphosphateCOVID-19pathological conditions signs and symptomsdigestive system diseasesCOVID-19 Drug TreatmentAmino acidsurgical procedures operative030104 developmental biologyEnzymechemistryBiochemistry030220 oncology & carcinogenesisSpike Glycoprotein CoronavirusNanoparticlesAlkaline phosphataseAngiotensin-Converting Enzyme 2Protein BindingReceptors CoronavirusBiochemical Pharmacology
researchProduct

Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d[pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2

2015

Vascular Endothelial Growth Factor (VEGF) pathway has emerged as one of the most important positive modulators of Angiogenesis, a central process implicated in tumour growth and metastatic dissemination. This led to the design and development of anti-VEGF monoclonal antibodies and small-molecule ATP-competitive VEGFR-inhibitors. In this study, we describe the synthesis and the biological evaluation of novel 2-aryl substituted benzothiopyrano-fused pyrimidines 1a-i, 2a-i and 3a-i. The ability of the compounds to target the VEGF pathway was determined in vitro exploiting the compounds' antiproliferative efficacy against HUVEC cells. The VEGFR-2 inhibition was confirmed by enzymatic assays on …

Models MolecularAngiogenesisReceptor tyrosine kinaseCellAntineoplastic AgentsReceptor tyrosine kinaseBenzothiopyranopirimidines; Kinase inhibitors; Receptor tyrosine kinases; Tumor angiogenesis; VEGFR;Tumor angiogenesisStructure-Activity Relationshipchemistry.chemical_compoundVEGFRBenzothiopyranopirimidineCell Line TumorReceptor tyrosine kinasesDrug DiscoveryHuman Umbilical Vein Endothelial CellsmedicineHumansProtein Kinase InhibitorsCell ProliferationPyransTumor angiogenesiPharmacologyKinase inhibitorDose-Response Relationship DrugMolecular StructurebiologyKinaseCell growthOrganic ChemistryKinase insert domain receptorGeneral MedicineVascular Endothelial Growth Factor Receptor-2Molecular biologyVascular endothelial growth factorPyrimidinesmedicine.anatomical_structureBenzothiopyranopirimidineschemistryBenzothiopyranopirimidines; Kinase inhibitors; Receptor tyrosine kinases; Tumor angiogenesis; VEGFRKinase inhibitorsCancer researchbiology.proteinDrug Screening Assays AntitumorEx vivo
researchProduct